Go Pro

FG Nexus (FGNX) Competitors

FG Nexus logo
$7.11 -0.48 (-6.32%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$7.14 +0.03 (+0.49%)
As of 08/14/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

FGNX vs. CNTN, HSDT, BNC, DFDV, and NAKA

Should you buy FG Nexus stock or one of its competitors? FG Nexus's main competitors and comparable companies include Hillstream Biopharma (CNTN), Solana (HSDT), CEA Industries (BNC), DeFi Development (DFDV), and KindlyMD (NAKA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does FG Nexus compare to Hillstream Biopharma?

Hillstream Biopharma (NASDAQ:CNTN) and FG Nexus (NASDAQ:FGNX) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

In the previous week, FG Nexus had 2 more articles in the media than Hillstream Biopharma. MarketBeat recorded 5 mentions for FG Nexus and 3 mentions for Hillstream Biopharma. Hillstream Biopharma's average media sentiment score of 1.89 beat FG Nexus' score of 1.63 indicating that Hillstream Biopharma is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hillstream Biopharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
FG Nexus
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

FG Nexus has a consensus price target of $35.00, suggesting a potential upside of 392.26%. Given FG Nexus' stronger consensus rating and higher possible upside, analysts clearly believe FG Nexus is more favorable than Hillstream Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hillstream Biopharma
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
FG Nexus
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Hillstream Biopharma has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, FG Nexus has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

Hillstream Biopharma has higher earnings, but lower revenue than FG Nexus. Hillstream Biopharma is trading at a lower price-to-earnings ratio than FG Nexus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hillstream BiopharmaN/AN/A-$35.92M-$1.15N/A
FG Nexus$2.41M15.05-$66.74M$12.770.56

1.2% of Hillstream Biopharma shares are owned by institutional investors. Comparatively, 3.1% of FG Nexus shares are owned by institutional investors. 3.3% of Hillstream Biopharma shares are owned by insiders. Comparatively, 4.1% of FG Nexus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Hillstream Biopharma has a net margin of 0.00% compared to FG Nexus' net margin of -4,888.86%. Hillstream Biopharma's return on equity of -31.50% beat FG Nexus' return on equity.

Company Net Margins Return on Equity Return on Assets
Hillstream BiopharmaN/A -31.50% -24.72%
FG Nexus -4,888.86%-95.68%-75.45%

Summary

FG Nexus beats Hillstream Biopharma on 9 of the 15 factors compared between the two stocks.

How does FG Nexus compare to Solana?

FG Nexus (NASDAQ:FGNX) and Solana (NASDAQ:HSDT) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

Solana has a net margin of -1,427.15% compared to FG Nexus' net margin of -4,888.86%. Solana's return on equity of -67.57% beat FG Nexus' return on equity.

Company Net Margins Return on Equity Return on Assets
FG Nexus-4,888.86% -95.68% -75.45%
Solana -1,427.15%-67.57%-24.09%

In the previous week, Solana had 5 more articles in the media than FG Nexus. MarketBeat recorded 10 mentions for Solana and 5 mentions for FG Nexus. FG Nexus' average media sentiment score of 1.63 beat Solana's score of 0.97 indicating that FG Nexus is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FG Nexus
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Solana
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

FG Nexus has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Solana has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market.

FG Nexus currently has a consensus target price of $35.00, indicating a potential upside of 392.26%. Solana has a consensus target price of $3.50, indicating a potential upside of 105.88%. Given FG Nexus' higher possible upside, equities analysts plainly believe FG Nexus is more favorable than Solana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FG Nexus
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Solana
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

3.1% of FG Nexus shares are held by institutional investors. Comparatively, 18.6% of Solana shares are held by institutional investors. 4.1% of FG Nexus shares are held by insiders. Comparatively, 14.4% of Solana shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Solana has higher revenue and earnings than FG Nexus. Solana is trading at a lower price-to-earnings ratio than FG Nexus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FG Nexus$2.41M15.05-$66.74M$12.770.56
Solana$6.02M16.49-$40.89M-$109.67N/A

Summary

Solana beats FG Nexus on 11 of the 17 factors compared between the two stocks.

How does FG Nexus compare to CEA Industries?

CEA Industries (NASDAQ:BNC) and FG Nexus (NASDAQ:FGNX) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

In the previous week, FG Nexus had 2 more articles in the media than CEA Industries. MarketBeat recorded 5 mentions for FG Nexus and 3 mentions for CEA Industries. FG Nexus' average media sentiment score of 1.63 beat CEA Industries' score of 0.62 indicating that FG Nexus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CEA Industries
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
FG Nexus
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

3.1% of FG Nexus shares are held by institutional investors. 2.7% of CEA Industries shares are held by insiders. Comparatively, 4.1% of FG Nexus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CEA Industries has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market. Comparatively, FG Nexus has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market.

CEA Industries has a net margin of 392.91% compared to FG Nexus' net margin of -4,888.86%. CEA Industries' return on equity of 81.62% beat FG Nexus' return on equity.

Company Net Margins Return on Equity Return on Assets
CEA Industries392.91% 81.62% 67.22%
FG Nexus -4,888.86%-95.68%-75.45%

CEA Industries has higher revenue and earnings than FG Nexus. CEA Industries is trading at a lower price-to-earnings ratio than FG Nexus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CEA Industries$27.99M3.85$115.26M$5.650.46
FG Nexus$2.41M15.05-$66.74M$12.770.56

FG Nexus has a consensus target price of $35.00, suggesting a potential upside of 392.26%. Given FG Nexus' stronger consensus rating and higher probable upside, analysts clearly believe FG Nexus is more favorable than CEA Industries.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CEA Industries
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
FG Nexus
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

FG Nexus beats CEA Industries on 11 of the 16 factors compared between the two stocks.

How does FG Nexus compare to DeFi Development?

DeFi Development (NASDAQ:DFDV) and FG Nexus (NASDAQ:FGNX) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

In the previous week, DeFi Development had 2 more articles in the media than FG Nexus. MarketBeat recorded 7 mentions for DeFi Development and 5 mentions for FG Nexus. FG Nexus' average media sentiment score of 1.63 beat DeFi Development's score of 1.07 indicating that FG Nexus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DeFi Development
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
FG Nexus
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

DeFi Development has a net margin of -1,319.45% compared to FG Nexus' net margin of -4,888.86%. DeFi Development's return on equity of 13.02% beat FG Nexus' return on equity.

Company Net Margins Return on Equity Return on Assets
DeFi Development-1,319.45% 13.02% 4.52%
FG Nexus -4,888.86%-95.68%-75.45%

DeFi Development has a beta of -3.94, suggesting that its stock price is 494% less volatile than the broader market. Comparatively, FG Nexus has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market.

FG Nexus has lower revenue, but higher earnings than DeFi Development. DeFi Development is trading at a lower price-to-earnings ratio than FG Nexus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DeFi Development$15.09M6.13-$73.79M-$9.98N/A
FG Nexus$2.41M15.05-$66.74M$12.770.56

0.5% of DeFi Development shares are owned by institutional investors. Comparatively, 3.1% of FG Nexus shares are owned by institutional investors. 23.6% of DeFi Development shares are owned by company insiders. Comparatively, 4.1% of FG Nexus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

DeFi Development presently has a consensus target price of $4.70, suggesting a potential upside of 53.09%. FG Nexus has a consensus target price of $35.00, suggesting a potential upside of 392.26%. Given FG Nexus' higher probable upside, analysts plainly believe FG Nexus is more favorable than DeFi Development.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DeFi Development
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
FG Nexus
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

FG Nexus beats DeFi Development on 9 of the 16 factors compared between the two stocks.

How does FG Nexus compare to KindlyMD?

KindlyMD (NASDAQ:NAKA) and FG Nexus (NASDAQ:FGNX) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

KindlyMD currently has a consensus target price of $22.33, suggesting a potential upside of 353.01%. FG Nexus has a consensus target price of $35.00, suggesting a potential upside of 392.26%. Given FG Nexus' higher possible upside, analysts plainly believe FG Nexus is more favorable than KindlyMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
FG Nexus
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

3.1% of FG Nexus shares are held by institutional investors. 24.5% of KindlyMD shares are held by insiders. Comparatively, 4.1% of FG Nexus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, KindlyMD and KindlyMD both had 5 articles in the media. FG Nexus' average media sentiment score of 1.63 beat KindlyMD's score of 0.48 indicating that FG Nexus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KindlyMD
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
FG Nexus
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

KindlyMD has a net margin of -1,067.93% compared to FG Nexus' net margin of -4,888.86%. KindlyMD's return on equity of -55.86% beat FG Nexus' return on equity.

Company Net Margins Return on Equity Return on Assets
KindlyMD-1,067.93% -55.86% -37.14%
FG Nexus -4,888.86%-95.68%-75.45%

KindlyMD has a beta of 15.95, indicating that its stock price is 1,495% more volatile than the broader market. Comparatively, FG Nexus has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market.

KindlyMD has higher earnings, but lower revenue than FG Nexus. KindlyMD is trading at a lower price-to-earnings ratio than FG Nexus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KindlyMD$1.82M47.13-$52.23M-$43.20N/A
FG Nexus$2.41M15.05-$66.74M$12.770.56

Summary

KindlyMD beats FG Nexus on 7 of the 13 factors compared between the two stocks.

Get FG Nexus News Delivered to You Automatically

Sign up to receive the latest news and ratings for FGNX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FGNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FGNX vs. The Competition

MetricFG NexusFinancial Services IndustryFinance SectorNASDAQ Exchange
Market Cap$38.68M$27.11B$14.11B$13.10B
Dividend YieldN/A5.88%5.87%10.45%
P/E Ratio0.5618.5629.3425.28
Price / Sales15.05414.86513.8291.94
Price / CashN/A139.2237.4950.90
Price / Book0.753.073.716.24
Net Income-$66.74M$1.09B$1.31B$347.60M
7 Day Performance5.49%0.67%0.73%1.06%
1 Month Performance11.79%-1.14%1.52%0.81%
1 Year PerformanceN/A-10.88%12.46%20.90%

FG Nexus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FGNX
FG Nexus
3.2704 of 5 stars
$7.11
-6.3%
$35.00
+392.3%
N/A$38.68M$2.41M0.569
CNTN
Hillstream Biopharma
0.4176 of 5 stars
$1.87
+0.5%
N/AN/A$144.22MN/AN/A2
HSDT
Solana
2.4527 of 5 stars
$1.69
+0.6%
$3.50
+107.1%
-71.8%$98.67M$6.02MN/A30
BNC
CEA Industries
1.1868 of 5 stars
$2.35
+2.2%
N/AN/A$96.76M$29.33M0.4230
DFDV
DeFi Development
2.8985 of 5 stars
$2.89
+6.3%
$4.70
+62.6%
-84.3%$87.04M$11.39MN/AN/A

Related Companies and Tools


This page (NASDAQ:FGNX) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners